Back
Speaker illustration

Doctor Jiawen Li

Beijing (China)

Born in 1997, Li Jiawen is a postgraduate of Fuwai hospital in China. She is the first student of Professor Zhao Xueyan with research direction of inflammation and biomarkers in coronary artery disease.

Presentations

Interleukin-6 rs1800796 G/C polymorphism is associated with poor clinical outcomes in patients with coronary artery disease

Event: ESC Congress 2025

Topic: Leukocytes, Inflammation, Immunity

Session: Innovations in cardiovascular repair: immune, genetic, and therapeutic perspectives

Access
Like
Thumbnail

Interleukin 1B gene polymorphism is associated with poor clinical outcomes in patients with coronary artery disease

Event: ESC Congress 2025

Topic: Leukocytes, Inflammation, Immunity

Session: Immune modulation and inflammatory pathways in cardiovascular disease and myocarditis

Access
Like
Thumbnail

Interleukin-1B and ST2L/IL-33R and risk of clinical outcomes in patients with multi-vessel disease

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Prognostic factors and outcomes in chronic coronary syndromes

Access
Like
Thumbnail

Integrated Impact of hs-CRP, LDL-C and Lp(a) on Platelet Reactivity in Coronary Heart Disease Patients Receiving Dual Antiplatelet Therapy

Event: ESC Congress 2025

Topic: Biomarkers

Session: Biomarkers and molecular predictors in cardiovascular disease: from risk assessment to clinical application

Access
Like
Thumbnail

Remnant cholesterol is associated with platelet reactivity for patients with coronary artery disease underwent percutaneous coronary intervention

Event: ESC Congress 2024

Topic: Biomarkers

Session: Novel biomarkers for cardiovascular risk prediction

Access
Like
Thumbnail

ABO blood groups and platelet reactivity in patients with coronary artery disease undergoing percutaneous coronary intervention treated with clopidogrel

Event: ESC Congress 2024

Topic: Biomarkers

Session: Cancer and other risk factors for heart disease

Access
Like
Thumbnail

Low-density lipoprotein cholesterol levels and long-term bleeding in patients undergoing percutaneous coronary intervention: 5-year outcomes from a large cohort study

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease - Epidemiology, prognosis, outcome 5

Access
Like
Thumbnail

Different inflammatory markers reflect different platelet reactivties in percutaneous coronary intervention patients treated with clopidogrel: a large sample study from China

Event: ESC Congress 2021 - The Digital Experience

Topic: Inflammation

Session: Acute Coronary Syndromes ePosters

Access
Like
Thumbnail

Association between NPC1L1 and HMGCR gene polymorphisms with residual cholesterol risk in patients with premature triple-vessel disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Genetics, Epigenetics, ncRNA

Session: Basic science e-posters

Access
Like
Thumbnail

Correlation between NCP1L1 and HMGCR Gene Polymorphism and Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease

Event: ESC Congress 2020

Topic: Ischaemia, Infarction, Cardioprotection

Session: Molecular Mechanisms that Modulate Ischemia Injury

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources